INTRODUCTION: For children with cerebral palsy (CP), conducting self-care tasks may be difficult due to physical and cognitive problems. Accurate assessment of children with CP is needed for realistic ...
The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...